Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study

Overview of attention for article published in Frontiers in immunology, August 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 1 X post from an account with 33,273 followers.

New Research: Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study https://t.co/M2N2HTSElA #FrontiersIn #Immunology

07 Aug 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.